Structured Summary
Abstract
Myeloid-lymphoid leukemia protein is a transcription factor that maintains high levels of HOMEOTIC GENE expression during development. The GENE for myeloid-lymphoid leukemia protein is commonly disrupted in LEUKEMIA and combines with over 40 partner genes to form FUSION ONCOGENE PROTEINS.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
Synonyms
11 entry terms
- Acute Lymphoblastic Leukemia Protein 1
- MLL Proto-Oncogene Protein
- Mixed-Lineage Leukemia Protein
- Proto-Oncogene Proteins MLL
- Zinc Finger Protein HRX
- MLL Proto Oncogene Protein
- MLL, Proto-Oncogene Proteins
- Mixed Lineage Leukemia Protein
- Myeloid Lymphoid Leukemia Protein
- Proto Oncogene Proteins MLL
- Proto-Oncogene Protein, MLL
MeSH Record
Aspects Covered
30 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2006(1992)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Myeloid-Lymphoid Leukemia Protein. Medical Subject Headings (MeSH). 2026. Unique ID D051788. http://id.nlm.nih.gov/mesh/2026/D051788
- Myeloid-Lymphoid Leukemia Protein. In: Wikidata. https://www.wikidata.org/wiki/Q21102206